BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 22451733)

  • 1. Protective role of purified cysteine proteinases against Fasciola gigantica infection in experimental animals.
    El-Ahwany E; Rabia I; Nagy F; Zoheiry M; Diab T; Zada S
    Korean J Parasitol; 2012 Mar; 50(1):45-51. PubMed ID: 22451733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Host responses during experimental infection with Fasciola gigantica or Fasciola hepatica in Merino sheep I. Comparative immunological and plasma biochemical changes during early infection.
    Raadsma HW; Kingsford NM; Suharyanta ; Spithill TW; Piedrafita D
    Vet Parasitol; 2007 Feb; 143(3-4):275-86. PubMed ID: 17069976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel ex vivo immunoproteomic approach characterising Fasciola hepatica tegumental antigens identified using immune antibody from resistant sheep.
    Cameron TC; Cooke I; Faou P; Toet H; Piedrafita D; Young N; Rathinasamy V; Beddoe T; Anderson G; Dempster R; Spithill TW
    Int J Parasitol; 2017 Aug; 47(9):555-567. PubMed ID: 28455238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of cathepsin-L cysteine proteinase based Dot-enzyme-linked immunosorbent assay for the diagnosis of Fasciola gigantica infection in buffaloes.
    Varghese A; Raina OK; Nagar G; Garg R; Banerjee PS; Maharana BR; Kollannur JD
    Vet Parasitol; 2012 Feb; 183(3-4):382-5. PubMed ID: 22055612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccination of sheep with purified cysteine proteinases of Fasciola hepatica decreases worm fecundity.
    Wijffels GL; Salvatore L; Dosen M; Waddington J; Wilson L; Thompson C; Campbell N; Sexton J; Wicker J; Bowen F
    Exp Parasitol; 1994 Mar; 78(2):132-48. PubMed ID: 8119370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MM3-ELISA evaluation of coproantigen release and serum antibody production in sheep experimentally infected with Fasciola hepatica and F. gigantica.
    Valero MA; Ubeira FM; Khoubbane M; Artigas P; Muiño L; Mezo M; Pérez-Crespo I; Periago MV; Mas-Coma S
    Vet Parasitol; 2009 Jan; 159(1):77-81. PubMed ID: 19019548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fasciola hepatica and Fasciola gigantica: comparison of cellular response to experimental infection in sheep.
    Zhang WY; Moreau E; Hope JC; Howard CJ; Huang WY; Chauvin A
    Exp Parasitol; 2005 Nov; 111(3):154-9. PubMed ID: 16126202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective efficacy of liver fluke DNA vaccines: A systematic review and meta-analysis: Guiding novel vaccine development.
    Jayaraj R; Kumarasamy C; Norbury L; Piedrafita D; Smooker P
    Vet Parasitol; 2019 Mar; 267():90-98. PubMed ID: 30878093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune response of rats vaccinated orally with various plant-expressed recombinant cysteine proteinase constructs when challenged with Fasciola hepatica metacercariae.
    Kesik-Brodacka M; Lipiec A; Kozak Ljunggren M; Jedlina L; Miedzinska K; Mikolajczak M; Plucienniczak A; Legocki AB; Wedrychowicz H
    PLoS Negl Trop Dis; 2017 Mar; 11(3):e0005451. PubMed ID: 28333957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccine potential of recombinant saposin-like protein 2 against Fasciolosis gigantica in mice.
    Kueakhai P; Changklungmoa N; Riengrojpitak S; Chaichanasak P; Meemon K; Chaithirayanon K; Chantree P; Sansri V; Itagaki T; Sobhon P
    Vaccine; 2013 Nov; 31(47):5518-23. PubMed ID: 24075921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccine potential of inclusion bodies containing cysteine proteinase of Fasciola hepatica in calves and lambs experimentally challenged with metacercariae of the fluke.
    Wedrychowicz H; Kesik M; Kaliniak M; Kozak-Cieszczyk M; Jedlina-Panasiuk L; Jaros S; Plucienniczak A
    Vet Parasitol; 2007 Jun; 147(1-2):77-88. PubMed ID: 17481823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phage display-based vaccine with cathepsin L and excretory-secretory products mimotopes of Fasciola hepatica induces protective cellular and humoral immune responses in sheep.
    Villa-Mancera A; Olivares-Pérez J; Olmedo-Juárez A; Reynoso-Palomar A
    Vet Parasitol; 2021 Jan; 289():109340. PubMed ID: 33373968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peritoneal lavage cells of Indonesian thin-tail sheep mediate antibody-dependent superoxide radical cytotoxicity in vitro against newly excysted juvenile Fasciola gigantica but not juvenile Fasciola hepatica.
    Piedrafita D; Estuningsih E; Pleasance J; Prowse R; Raadsma HW; Meeusen EN; Spithill TW
    Infect Immun; 2007 Apr; 75(4):1954-63. PubMed ID: 17210661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protection against Fasciola gigantica using paramyosin antigen as a candidate for vaccine production.
    Abou-Elhakam H; Rabee I; El Deeb S; El Amir A
    Pak J Biol Sci; 2013 Nov; 16(22):1449-58. PubMed ID: 24511686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of humoral response in sheep to Fasciola hepatica and Fasciola gigantica experimental infection.
    Zhang W; Moreau E; Huang W; Chauvin A
    Parasite; 2004 Jun; 11(2):153-9. PubMed ID: 15224576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the immune response of male and female rats vaccinated with cDNA encoding a cysteine proteinase of Fasciola hepatica (FhPcW1).
    Wesołowska A; Norbury LJ; Januszkiewicz K; Jedlina L; Jaros S; Zawistowska-Deniziak A; Zygner W; Wędrychowicz H
    Acta Parasitol; 2013 Jun; 58(2):198-206. PubMed ID: 23666656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protection against Fasciola gigantica infection in mice by vaccination with recombinant juvenile-specific cathepsin L.
    Sansri V; Meemon K; Changklungmoa N; Kueakhai P; Chantree P; Chaichanasak P; Lorsuwannarat N; Itagaki T; Sobhon P
    Vaccine; 2015 Mar; 33(13):1596-601. PubMed ID: 25701317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fasciola gigantica enolase is a major component of worm tegumental fraction protective against sheep fasciolosis.
    Mahana N; Abd-Allah HA; Salah M; Tallima H; El Ridi R
    Acta Trop; 2016 Jun; 158():189-196. PubMed ID: 26970372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular characterisation and vaccine efficacy of two novel developmentally regulated surface tegument proteins of Fasciola hepatica.
    McCusker P; Toet H; Rathinasamy V; Young N; Beddoe T; Anderson G; Dempster R; McVeigh P; McCammick E; Wells D; Mousley A; Marks NJ; Maule AG; Spithill TW
    Vet Parasitol; 2020 Oct; 286():109244. PubMed ID: 32971381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fasciola gigantica excretory-secretory products for immunodiagnosis and prevention of sheep fasciolosis.
    El Ridi R; Salah M; Wagih A; William H; Tallima H; El Shafie MH; Abdel Khalek T; El Amir A; Abo Ammou FF; Motawi H
    Vet Parasitol; 2007 Nov; 149(3-4):219-28. PubMed ID: 17897786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.